Sirgel, F. A., Warren, R. M., Böttger, E. C., Klopper, M., Victor, T. C., & van Helden, P. D. (2013). The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. Public Library of Science.
استشهاد بنمط شيكاغوSirgel, Frederick A., Robin M. Warren, Erik C. Böttger, Marisa Klopper, Thomas C. Victor, و Paul D. van Helden. The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. Public Library of Science, 2013.
MLA استشهادSirgel, Frederick A., et al. The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. Public Library of Science, 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.